IMMUNE-RELATED ADVERSE EVENT
Clinical trials for IMMUNE-RELATED ADVERSE EVENT explained in plain language.
Never miss a new study
Get alerted when new IMMUNE-RELATED ADVERSE EVENT trials appear
Sign up with your email to follow new studies for IMMUNE-RELATED ADVERSE EVENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to tame liver side effects of cancer immunotherapy
Disease control Not yet recruitingThis study tests whether combining mycophenolate mofetil (MMF) with prednisone can better treat liver inflammation caused by checkpoint inhibitor cancer drugs. The trial includes adults with moderate to severe immune-related hepatitis who need to pause their cancer therapy. The m…
Matched conditions: IMMUNE-RELATED ADVERSE EVENT
Phase: PHASE2 • Sponsor: Fox Chase Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Blood filtering may tame severe immunotherapy side effects
Knowledge-focused Not yet recruitingThis study looks at whether a procedure called therapeutic plasma exchange—which filters the blood—can help remove immune checkpoint inhibitor drugs from the body in people who develop severe immune-related side effects from cancer treatment. The trial will measure how drug level…
Matched conditions: IMMUNE-RELATED ADVERSE EVENT
Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Aug 12, 2026 00:00 UTC